ALAD Porphyria Treatment
ALAD Porphyria, also known as δ-Aminolevulinic Acid Dehydratase (ALAD) Deficiency Porphyria or Doss Porphyria, is an extremely rare inherited metabolic disorder caused by a deficiency of the ALAD enzyme, which is involved in the synthesis of heme (an essential component of hemoglobin). The enzyme deficiency leads to the accumulation of δ-aminolevulinic acid (ALA), causing neurological and gastrointestinal symptoms.
Treatment focuses on reducing ALA production, managing acute attacks, preventing complications, and avoiding factors that can trigger symptoms. Because the condition is very rare, treatment is usually individualized under the care of specialists.
1 View